Patent details

Basic Information

Publication number:

EP1984402

PCT Application Number:

EP2006012632

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP068412311

PCT Publication Number:

WO2007077028

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF

French Title of Invention:

ANTICORPS DIRIGÉS CONTRE LE HER-3 ET LEURS UTILISATIONS

German Title of Invention:

GEGEN HER-3 GERICHTETER ANTIKÖRPER UND ANWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

29/12/2006

Grant date:

08/02/2017

EP Publication Date:

29/10/2008

PCT Publication Date:

12/07/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/02/2017

EP B1 Publication Date:

08/02/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/12/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/02/2017

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Name:

Daiichi Sankyo Europe GmbH

Address:

Zielstattstr. 48, 81379 München, Germany (DE)

Agent

Name:

WEICKMANN & WEICKMANN

From:

27/01/2017

Address:

Postfach 860 820, 81635, MÜNCHEN, Germany (DE)

To:

Inventor

1

Name:

HARTMANN, Susanne

Address:

Germany (DE)

2

Name:

TREDER, Martin

Address:

Germany (DE)

3

Name:

RADINSKY, Bob

Address:

United States (US)

4

Name:

ROTHE, Mike

Address:

Germany (DE)

5

Name:

BORGES, Eric

Address:

Austria (AT)

6

Name:

FREEMAN, Dan

Address:

United States (US)

Priority

Priority Number:

755103 P

Priority Date:

30/12/2005

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/00; C07K 16/28; C07K 16/32; G01N 33/574;

Publication

European Patent Bulletin

1

Issue number:

201706

Publication date:

08/02/2017

Description:

Grant (B1)

2

Issue number:

201711

Publication date:

15/03/2017

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

20

Annual Fee Amount:

300 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/12/2024

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
27/01/2017	Power Of Attorney	3